KLK3 and Familial prostate cancer: These results are consistent with the findings of a systematic review by Fenton et al,13 which concluded that an increased diagnostic activity (the introduction of PSA screening) reduced prostate cancer mortality but was associated with overdiagnosis and possibly overtreatment.1